Lincoln, NE, Sept. 22, 2017 -- NRC Health, the leading provider of patient and consumer insights and healthcare performance-improvement solutions, has launched the healthcare industry’s first holistic metric for measuring consumer loyalty: the NRC Health Loyalty Index. The Loyalty Index enables hospitals and healthcare systems to develop informed marketing strategies, drive patient acquisition, and enhance consumer loyalty.
Hospitals and healthcare systems who rely solely on a single metric to evaluate loyalty, such as patient experience scores, can miss the complete picture. One-dimensional views minimize opportunities to understand a healthcare consumer’s complete journey, including brand awareness and need, or motivation to use their brand over others. The NRC Health Loyalty Index, comprised of seven key attributes of the healthcare journey, provides a 360° view of healthcare consumer loyalty.
The Loyalty Index strengthens strategic healthcare decision-making. It provides marketers a unified way to assess and track brand strengths and weaknesses, benchmark against peers, and identify emerging trends in consumer behavior. With new insight, marketers now have the ability to proactively implement change, prove marketing ROI, and ultimately increase market share.
Brian Wynne, General Manager of Market Insights for NRC Health, said: “The development of the NRC Health Loyalty Index is a meaningful step towards defining and quantifying loyalty in healthcare. We are proud to be at the forefront in helping our partners understand the needs of the communities they serve and transform the way they deliver care.”
The NRC Health Loyalty Index is powered by the NRC Health Market Insights solution. Market Insights provides marketers and strategists with the nation’s largest syndicated healthcare consumer database, capturing insights from 300,000+ consumers annually in more than 300 markets across the U.S.
To learn more about the NRC Health Loyalty Index, stop by booth #601 at SHSMD, September 24-27 in Orlando, FL, and booth #30 at HCIC, October 23-25 in Austin, TX.
About NRC Health
NRC Health (NASDAQ: NRCIA and NRCIB) has helped healthcare organizations illuminate and improve the moments that matter to patients, residents, physicians, nurses, and staff for 35 years. Our empathetic heritage, proprietary methods, and holistic approach enable our partners to better understand the people they care for and, in turn, design experiences that inspire loyalty and trust.
For more information, call 1-800-388-4264, write to [email protected], or visit www.nrchealth.com.
|
|||
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/fe7ec2e2-ced5-42dc-8503-6c6b079e652e
Kristine German NRC Health 4024752525 [email protected]


Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
Italy Fines Apple €98.6 Million Over App Store Dominance
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy
TSMC Honors Japanese Chip Equipment Makers With 2025 Supplier Awards
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Warner Bros. Discovery Shares Slide Amid Report of Potential Paramount Skydance Lawsuit
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio 



